Products for Research Use Only
RegisterLogin

Daxdilimab

CAT: 0804-HY-P99226-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99226-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research[1][2].
CAS Number
2245966-28-1
Product Name Alternative
MEDI7734; VIB7734
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/daxdilimab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Daxdilimab]
Molecular Weight
(144.38 kDa)
References & Citations
[1]Patel S, et al. Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19. Heliyon. 2021 Feb;7 (2) :e06158.|[2]Retamozo S, et al. An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development. Expert Opin Pharmacother. 2021 Dec;22 (17) :2359-2371.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
abx831621-01Daxdilimab
GTR18338018-01Daxdilimab Antibody
MBS1563755-01Research Grade Daxdilimab
E55B0782Daxdilimab (Reference antibody)
591782-01LILRA4 (Daxdilimab Biosimilar)
MBS3030449-01Daxdilimab Biosimilar - Research Grade
ABS-297-1mgDaxdilimab Biosimilar, Research Grade
21-899Daxdilimab - Research Grade Biosimilar
A138274Daxdilimab Biosimilar (Monoclonal, IgG1)
GTR18780525-01(Daxdilimab) Biosimilar Reference Antibody

Popular Products